About Us

Holly Lynch is a results-driven strategist with a passion for leveraging digital technology, artificial intelligence (AI), and data to transform the way new medicines are discovered and developed. With a proven ability to translate visionary ideas into actionable strategies, she has built a distinguished career guiding organizations through AI adoption, digital transformation, and business growth.

With extensive experience across biotech, pharma, and life sciences, Holly excels at building strategic partnerships, integrating automation and AI into research workflows, and optimizing business operations to drive efficiency and scalability. She has played a pivotal role in AI-powered drug discovery, digital pathology advancements, and robotics-enabled laboratory operations.

Her leadership spans multiple high-impact roles, including Senior Director of Digital Strategy at Charles River, where she developed AI-driven platforms, built industry partnerships, and launched digital solutions that have reshaped drug discovery. As a sought-after consultant and advisor, she now collaborates with cutting-edge life sciences firms, helping them define and execute strategies in AI, digitalization, and operational excellence.

Holly holds an MBA with a focus on accounting and a Bachelor of Science in Biology. She is known for her collaborative leadership, strategic vision, and ability to bridge the gap between science, technology, and business to create industry-leading solutions.